These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17213734)

  • 41. Clopidogrel and [symbol: see text] ticlopidine--improvements on aspirin?
    Drug Ther Bull; 1999 Aug; 37(8):59-61. PubMed ID: 10696686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using clopidogrel bisulfate: a new antiplatelet drug.
    Pfister SM
    Nurse Pract; 1999 Sep; 24(9):100-1, 105-8, 110. PubMed ID: 10507077
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term combination therapy with aspirin and clopidogrel.
    Kumana CR; Cheung G; Lauder IJ; Cheung BM
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):223-5. PubMed ID: 15678241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 45. Ticlopidine and clopidogrel.
    Quinn MJ; Fitzgerald DJ
    Circulation; 1999 Oct; 100(15):1667-72. PubMed ID: 10517740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P; Stenestrand U; Malmberg K; Jönsson B
    Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clopidogrel: new indication. In combination with aspirin: marginal additional benefits.
    Prescrire Int; 2007 Aug; 16(90):146. PubMed ID: 17724837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effectiveness review of antiplatelet agents in peripheral artery disease.
    Schmit K; Dolor RJ; Jones WS; Vemulapalli S; Hasselblad V; Subherwal S; Heidenfelder B; Patel MR
    J Am Heart Assoc; 2014 Dec; 3(6):e001330. PubMed ID: 25477329
    [No Abstract]   [Full Text] [Related]  

  • 49. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clopidogrel--an expensive thrombocyte inhibitor with a small marginal benefit].
    Asplund K
    Lakartidningen; 2000 Mar; 97(11):1294-6. PubMed ID: 10771550
    [No Abstract]   [Full Text] [Related]  

  • 51. ACTIVE A: balancing the benefits and risks of clopidogrel and aspirin.
    Boysen G
    Lancet Neurol; 2009 Jun; 8(6):507-8. PubMed ID: 19446266
    [No Abstract]   [Full Text] [Related]  

  • 52. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone.
    Rothberg M
    Ann Intern Med; 2005 Sep; 143(6):464; author reply 464-5. PubMed ID: 16172448
    [No Abstract]   [Full Text] [Related]  

  • 53. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone.
    Eriksson P
    Ann Intern Med; 2005 Sep; 143(6):464; author reply 464-5. PubMed ID: 16172447
    [No Abstract]   [Full Text] [Related]  

  • 54. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.
    Gaspoz JM; Coxson PG; Goldman PA; Williams LW; Kuntz KM; Hunink MG; Goldman L
    N Engl J Med; 2002 Jun; 346(23):1800-6. PubMed ID: 12050341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The most important aspects of risk assessment].
    Wilhelm TJ; Post S
    Zentralbl Chir; 2013 Jun; 138(3):219-21. PubMed ID: 23967446
    [No Abstract]   [Full Text] [Related]  

  • 56. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
    Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Brennan DM; Fabry-Ribaudo L; Booth J; Topol EJ;
    N Engl J Med; 2006 Apr; 354(16):1706-17. PubMed ID: 16531616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Thienopyridines in the treatment and prevention of cardiovascular diseases. III. therapeutic application of clopidogrel as monotherapy (without acetylsalicylic acid)].
    Preobrazhenskiĭ DV; Sidorenko BA; Batyraliev TA; Vural A; Islek M; Avsar O; Fettser DV
    Kardiologiia; 2009; 49(12):63-7. PubMed ID: 20038285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New antiplatelet agents (platelet receptor blockers): has aspirin come out of place?].
    Tsakiris DA
    Praxis (Bern 1994); 2004 Jun; 93(23):1003-5. PubMed ID: 15233569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.